 | • レポートコード：QYR9N7611 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・骨髄異形成症候群（MDS）薬の世界市場規模 ・主要企業別市場シェア ・骨髄異形成症候群（MDS）薬の世界市場規模：種類別（低メチル化剤、免疫調節薬、抗貧血薬） ・骨髄異形成症候群（MDS）薬の世界市場規模：用途別（オリジナル、ジェネリック） ・骨髄異形成症候群（MDS）薬のアメリカ市場規模（種類別、用途別） ・骨髄異形成症候群（MDS）薬のヨーロッパ市場規模（種類別、用途別） ・骨髄異形成症候群（MDS）薬の中国市場規模（種類別、用途別） ・骨髄異形成症候群（MDS）薬の日本市場規模（種類別、用途別） ・骨髄異形成症候群（MDS）薬の東南アジア市場規模（種類別、用途別） ・骨髄異形成症候群（MDS）薬のインド市場規模（種類別、用途別） ・骨髄異形成症候群（MDS）薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・骨髄異形成症候群（MDS）薬の世界市場予測（2019年-2025年） ・骨髄異形成症候群（MDS）薬の地域別市場予測（2019年-2025年） ... |
Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximately 10,000-15,000 new cases are reported each year. Patients may present with clinical manifestations such as thrombocytopenia, neutropenia, and anemia. Exposure to chemicals (such as pesticides, tobacco, and benzene) and heavy metals (such as mercury and lead) may trigger disease onset.In recent years, demand for hypomethylating agents has been at a high due to approval and adoption of Vidaza and Dacogen. A strong pipeline including Aranesp is expected to boost market growth in the near future. Easy availability of and access to novel treatments in major countries provides strong commercial opportunities to the market.
In 2018, the global Myelodysplastic Syndrome (MDS) Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Myelodysplastic Syndrome (MDS) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myelodysplastic Syndrome (MDS) Drugs development in United States, Europe and China.
The key players covered in this study
Celgene
Amgen
Otsuka
Takeda
…
Market segment by Type, the product can be split into
Hypomethylating Agents
Immunomodulatory Drugs
Anti-anemics
Market segment by Application, split into
Original
Generics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Myelodysplastic Syndrome (MDS) Drugs status, future forecast, growth opportunity, key market and key players.
To present the Myelodysplastic Syndrome (MDS) Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Myelodysplastic Syndrome (MDS) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Myelodysplastic Syndrome (MDS) Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Hypomethylating Agents
1.4.3 Immunomodulatory Drugs
1.4.4 Anti-anemics
1.5 Market by Application
1.5.1 Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2025)
1.5.2 Original
1.5.3 Generics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Myelodysplastic Syndrome (MDS) Drugs Market Size
2.2 Myelodysplastic Syndrome (MDS) Drugs Growth Trends by Regions
2.2.1 Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions (2014-2025)
2.2.2 Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Myelodysplastic Syndrome (MDS) Drugs Market Size by Manufacturers
3.1.1 Global Myelodysplastic Syndrome (MDS) Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Myelodysplastic Syndrome (MDS) Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Myelodysplastic Syndrome (MDS) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Myelodysplastic Syndrome (MDS) Drugs Key Players Head office and Area Served
3.3 Key Players Myelodysplastic Syndrome (MDS) Drugs Product/Solution/Service
3.4 Date of Enter into Myelodysplastic Syndrome (MDS) Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019)
4.2 Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
5.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in United States
5.3 United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
5.4 United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
6 Europe
6.1 Europe Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
6.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Europe
6.3 Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
6.4 Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
7 China
7.1 China Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
7.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in China
7.3 China Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
7.4 China Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
8 Japan
8.1 Japan Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
8.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Japan
8.3 Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
8.4 Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
9.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Southeast Asia
9.3 Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
9.4 Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
10 India
10.1 India Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
10.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in India
10.3 India Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
10.4 India Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size (2014-2019)
11.2 Myelodysplastic Syndrome (MDS) Drugs Key Players in Central & South America
11.3 Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Type
11.4 Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Application
12 International Players Profiles
12.1 Celgene
12.1.1 Celgene Company Details
12.1.2 Company Description and Business Overview
12.1.3 Myelodysplastic Syndrome (MDS) Drugs Introduction
12.1.4 Celgene Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
12.1.5 Celgene Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Myelodysplastic Syndrome (MDS) Drugs Introduction
12.2.4 Amgen Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Otsuka
12.3.1 Otsuka Company Details
12.3.2 Company Description and Business Overview
12.3.3 Myelodysplastic Syndrome (MDS) Drugs Introduction
12.3.4 Otsuka Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
12.3.5 Otsuka Recent Development
12.4 Takeda
12.4.1 Takeda Company Details
12.4.2 Company Description and Business Overview
12.4.3 Myelodysplastic Syndrome (MDS) Drugs Introduction
12.4.4 Takeda Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
12.4.5 Takeda Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Myelodysplastic Syndrome (MDS) Drugs Key Market Segments
Table Key Players Myelodysplastic Syndrome (MDS) Drugs Covered
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Market Share by Type 2014-2025
Figure Hypomethylating Agents Figures
Table Key Players of Hypomethylating Agents
Figure Immunomodulatory Drugs Figures
Table Key Players of Immunomodulatory Drugs
Figure Anti-anemics Figures
Table Key Players of Anti-anemics
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Original Case Studies
Figure Generics Case Studies
Figure Myelodysplastic Syndrome (MDS) Drugs Report Years Considered
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2025 (Million US$)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions 2014-2019
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions 2014-2019
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Myelodysplastic Syndrome (MDS) Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Manufacturers (2014-2019)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Share by Manufacturers in 2018
Table Global Myelodysplastic Syndrome (MDS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Myelodysplastic Syndrome (MDS) Drugs Product/Solution/Service
Table Date of Enter into Myelodysplastic Syndrome (MDS) Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Type (2014-2019)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Market Share by Type (2014-2019)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Application (2014-2019)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Market Share by Application (2014-2019)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Revenue Market Share by Application in 2018
Figure United States Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table United States Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Figure Europe Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Figure China Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table China Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-20189) (Million US$)
Table China Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table China Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table China Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Figure Japan Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Figure India Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table India Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table India Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table India Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table India Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Figure Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Myelodysplastic Syndrome (MDS) Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Myelodysplastic Syndrome (MDS) Drugs Market Share (2018-2019)
Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Share by Type (2014-2019)
Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Share by Application (2014-2019)
Table Celgene Company Details
Table Celgene Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019) (Million US$)
Figure Celgene Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
Table Celgene Recent Development
Table Amgen Company Details
Table Amgen Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
Table Amgen Recent Development
Table Otsuka Company Details
Table Otsuka Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)(Million US$)
Figure Otsuka Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
Table Otsuka Recent Development
Table Takeda Company Details
Table Takeda Revenue in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Myelodysplastic Syndrome (MDS) Drugs Business (2014-2019)
Table Takeda Recent Development
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Regions (2019-2025)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size Share by Regions in 2025
Figure United States Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Myelodysplastic Syndrome (MDS) Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Product (2019-2025)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Product in 2025
Table Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application (2019-2025)
Figure Global Myelodysplastic Syndrome (MDS) Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のセロトニン症候群市場：市場規模・現状・予測 Serotonin syndrome is a group of symptoms such as high body temperature, agitation, increased reflexes, tremor, sweating, dilated pupils, diarrhoea etc. due to use of serotonergic drugs. Serious complications such as seizures and extensive muscle breakdown may occur which may lead to death.US accoun…- 世界のセロトニン症候群の治療市場：市場規模・現状・予測 Serotonin syndrome refers to a group of symptoms and signs caused by the hyperfunction of serotonin in the nervous system, which is manifested as the triad of cognitive function/behavior change, neuromuscular abnormality and autonomic nervous instability.In 2018, the global Serotonin Syndrome Treatm…
- 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の鼻出血薬市場：市場規模・現状・予測 A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils.Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to cr…
- 世界の悪性神経膠腫薬市場：市場規模・現状・予測 Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive tumors among the deadliest human cancers.In the Malignant Glioma Market the largest market share is gained by the U.S. where there are large incidence and pr…